WHO ICTRP trial
Evaluation of constrast enhanced MRI for therapeutic decisions in acute stroke…
DRKS00005197 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00005197 |
|---|---|
| Public title | Evaluation of constrast enhanced MRI for therapeutic decisions in acute stroke with follow-up MRI |
| Scientific title | Evaluation of constrast enhanced MRI for therapeutic decisions in acute stroke with follow-up MRI |
| Primary sponsor | Universitätsklinikum Freiburg |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | I63;Cerebral infarction |
| Interventions | Group 1: Patients with acute stroke recieve a MRI exam within 72 hours after admission including contrast enhanced perfusion imaging and will be additionally evaluated after clinical criteria on discharge and 90 days after admission. |
| Registration date | Nov 9, 2013 |
| Target size | 100 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: